News
Latest news and informative articlesNews
Q1 2025 Newsletter – What’s New in Clinical Development Practices & Regulations
Regulatory update compiled by our experts
EMA’s Data Management Services; an introduction to SPOR
Introduction to Substances, Products, Organisations and Referentials (SPOR)
S-cubed Ltd is excited to announce that it has joined the athagoras group
Joining the athagoras group at this exciting time will allow us to expand the range of services that we currently offer to our clients…
Q4 2024 Newsletter – What’s New in Clinical Development Practices & Regulations
Regulatory update compiled by our experts
EMA New Fee Regulation
Update following EMA webinar
Q3 2024 Newsletter – What’s New in Clinical Development Practices & Regulations
Regulatory update compiled by our experts
Q2 2024 Newsletter – What’s New in Clinical Development Practices & Regulations
Regulatory update compiled by our experts
Clinical Data Publication
Transparency requirements for publication of clinical data
Proposal to amend the MDR and IVDR
Extension of transition period for certain IVDs, gradual introduction of EUDAMED, and mitigation of supply shortages
Q1 2024 Newsletter – What’s New in Clinical Development Practices & Regulations
Regulatory update compiled by our experts
Clinical Data Publication
Relaunch of Policy 70
Q4 2023 Newsletter – What’s New in Clinical Development Practices & Regulations
Regulatory update compiled by our experts
Proposed EMA fee regulation
New proposed regulation to revise the fees charged by the EMA
Clinical Trial Legislation in the UK
MHRA announces a new notification scheme for low risk clinical trials
Free ‘Portfolio and Technology’ meeting with the European Medicines Agency
Hurry! Less than two weeks remaining to apply
EMA revised transparency rules for CTIS
EMA announces removal of the deferral mechanism for clinical trial publications
Implementation of the Windsor Framework
Planned changes to UK MAs and the impact on product packaging
The future of Orphan Medicines in the EU
Impact of EC draft changes to the Pharmaceutical Regulations.
Q3 2023 Newsletter – What’s New in Clinical Development Practices & Regulations
Regulatory update compiled by our experts
Draft EMA Reflection Paper on Artificial Intelligence
EMA considerations on the use of AI in the medicinal product lifecycle.
S-cubed Denmark (ApS) acquired by Phastar
We are happy to announce that S-cubed Denmark (ApS) has been acquired by Phastar.
Articles
S-cubed Ltd is excited to announce that it has joined the athagoras group
Joining the athagoras group at this exciting time will allow us to expand the range of services that we currently offer to our clients…
Clinical Trial Legislation in the UK
MHRA announces a new notification scheme for low risk clinical trials
Draft EMA Reflection Paper on Artificial Intelligence
EMA considerations on the use of AI in the medicinal product lifecycle.
INDUSTRY INSIGHTS
Sign up to receive our newsletters
Our Industry Insights features the latest news and developments from the pharmaceutical industry.
Sign up for our newsletter
Download our latest publication
Featured in this issue of Industry Insights:
- Worldwide Initiatives for Clinical Trials
- Regulations and ICH GxP Guidelines
- Data Transparency
- Medical Devices
- Draft and Final Guidance Documents
If you want to contribute or share something that you’d like to be listed in the next issue, please feel free to contact us.